Page 63 - Eshre 2018

Bibliography.
Oosterhuis JW, Looijenga LHJ. Testicular germ cell tumors in a broader perspective. Nat Cancer Rev: 2005;5:210-222.
De Jong J, Stoop J, Gillis AJM, Van Gurp RJHLM, Van de Geijn JGM, De Boer M, Hersmus R, Saunders PTK, Anderson RA, Oosterhuis JW, Looijenga LHJ. Differential expression of SOX17 and SOX2 in human normal and malignant germ cells and stem cells has biological and clinical implications. J. Pathol. 2008: 215: 21-30.
Stoop H, Kirkels W, Dohle GR, Gillis AJM, Den Bakker MA, Biermann K, Oosterhuis JW, Looijenga LHJ. Diagnosis of testicular carcinoma in situ, (intratubular- and micro-invasive) seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections. Histopathology 2011; 58(3): 440-446.
Van der Zwan Y, Biermann K, Wolffenbuttel KP, Cools M, Looijenga LHJ. Novel insights in gonadal development as risk factor for germ cell cancer: towards a clinical decision model. Eur Urol. 2015; 67(4):692-701.
Van Agthoven AJ, Looijenga LHJ. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget 2017; 8(35):58037-58049.
WHO Classification of Tumors of the Urinary System and Male Genital Organs. 4th Edition, 2016:pages 185-226 & 236-237.
Van Agthoven T, Eijkenboom WMH, Looijenga LHJ. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients. Cell Oncol (Dordr). 2017; Aug;40(4):379-388.
Page 57 of 130
PRECONGRESS COURSE 01 I BARCELONA, SPAIN – 1 JULY 2018 63